A new on-column derivatization method based on the redox activity of porous graphitic carbon (PGC) packing materials was presented for enhancement of separation selectivity of HPLC. Two PGC packing materials were used as the solid redox agents as well as the stationary phase, and their redox activities were investigated using trans-1,2-diaminocyclohexanetetraacetate (DCTA) complexes of some metal ions as probe compounds. It was found that the redox property of PGC was modified by treating them with a solution containing a reducing agent, sodium sulfite or hydroxylammonium chloride. The original PGC packings oxidized Co(II)-DCTA to Co(III)-DCTA during elution, while the PGC treated with a reducing agent showed reduction activity converting Co(III)-DCTA to Co(II)-DCTA. These two cobalt complexes do not form their individual chromatographic zones but migrate as a single zone of their mixture on the PGC column contrary to the chromatographic behavior on a C18 bonded silica, on which Co(II)-DCTA and Co(III)-DCTA can be separated. Treatment of the PGC column with a reducing agent solution transforms the oxidative activity of the original PGC packing to a reductive one from the upper part of the column, so that the retention time of the cobalt complex can be controlled by changing the volume of the reducing agent solution to be used for treatment of the PGC column. The selective separation and determination of cobalt in a reference manganese nodule sample by the developed method was demonstrated.

Download full-text PDF

Source
http://dx.doi.org/10.1021/ac020705eDOI Listing

Publication Analysis

Top Keywords

reducing agent
16
pgc packing
12
pgc column
12
pgc
9
on-column derivatization
8
redox activity
8
activity porous
8
porous graphitic
8
graphitic carbon
8
stationary phase
8

Similar Publications

Modulation of Intestinal Inflammation and Protection of Dopaminergic Neurons in Parkinson's Disease Mice through a Probiotic Formulation Targeting NLRP3 Inflammasome.

J Neuroimmune Pharmacol

January 2025

Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, PR China.

Emerging evidence highlights the significance of peripheral inflammation in the pathogenesis of Parkinson's disease (PD) and suggests the gut as a viable therapeutic target. This study aimed to explore the neuroprotective effects of the probiotic formulation VSL#3 and its underlying mechanism in a PD mouse model induced by MPTP. Following MPTP administration, the striatal levels of dopamine and its metabolites, as along with the survival rate of dopaminergic neurons in the substantia nigra, were significantly reduced in PD mice.

View Article and Find Full Text PDF

Antibody-drug conjugates (ADCs) have emerged as a promising strategy in targeted cancer therapy, enabling the precise delivery of cytotoxic agents to tumor sites while minimizing systemic toxicity. However, traditional ADCs face significant limitations, including restricted drug loading capacity, where an optimal drug-to-antibody ratio (DAR) is crucial; low DARs may lead to insufficient potency, while high DARs can cause rapid clearance and increased toxicity. Additionally, ADCs often suffer from instability in circulation due to the potential for premature release of cytotoxic agents, resulting in off-target effects and reduced therapeutic efficacy.

View Article and Find Full Text PDF

The study evaluated the anti-hyperlipidemic effects of myrcenol and curzerene on a high fat diet induced hyperlipidemia rat model. Thirty male albino rats were fed on a high-fat diet for four months. The HFD-induced hyperperlipidemia rats were treated with rosuvastatin (10 mg/kg), curzerene (130 mg/kg) and myrcenol (100 mg/kg) for four weeks.

View Article and Find Full Text PDF

Background: High blood pressure is a prevalent condition in patients with chronic kidney disease on hemodialysis. Adequate control of high blood pressure is essential to reducing deaths in this group. The present study aimed to observe mortality prospectively in a group of patients in hemodialysis and hemodiafiltration programs in whom the use of antihypertensives was optimized with the point-of-care dry weight (POC-DW) technique.

View Article and Find Full Text PDF

Background: Early and accurate diagnosis of drug resistance, including resistance to second-line anti-tuberculosis (TB) drugs, is crucial for the effective control and management of pre-extensively drug-resistant TB (pre-XDR-TB) and extensively drug-resistant TB (XDR-TB). The Xpert MTB/XDR assay is the WHO recommended method for detecting resistance to isoniazid and second-line anti-TB drugs when rifampicin resistance is detected. Currently, the Xpert MTB/XDR assay is not yet implemented in Ethiopia, thus the MTBDRsl assay continues to be used.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!